Cargando…

Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study

BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lye, Jennifer M., Knight, Julia A., Arneja, Jasleen, Seeto, Ryan A., Wong, Jody, Adel khani, Nadya, Brooks, Jennifer D., Levitan, Robert D., Matthews, Stephen G., Lye, Stephen J., Hung, Rayjean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261144/
https://www.ncbi.nlm.nih.gov/pubmed/35794252
http://dx.doi.org/10.1038/s41390-022-02182-w
_version_ 1784742207956189184
author Lye, Jennifer M.
Knight, Julia A.
Arneja, Jasleen
Seeto, Ryan A.
Wong, Jody
Adel khani, Nadya
Brooks, Jennifer D.
Levitan, Robert D.
Matthews, Stephen G.
Lye, Stephen J.
Hung, Rayjean J.
author_facet Lye, Jennifer M.
Knight, Julia A.
Arneja, Jasleen
Seeto, Ryan A.
Wong, Jody
Adel khani, Nadya
Brooks, Jennifer D.
Levitan, Robert D.
Matthews, Stephen G.
Lye, Stephen J.
Hung, Rayjean J.
author_sort Lye, Jennifer M.
collection PubMed
description BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This study aimed to characterize the relationship between maternal acetaminophen use and cognitive development at 4 years. METHODS: This analysis included data collected throughout pregnancy and delivery from women in the Ontario Birth Study prospective cohort from 2013 to 2019 and from the NIH Toolbox Early Childhood Cognition battery administered to 4-year-old children between 2018 and 2021 (n = 436). The exposure was maternal acetaminophen use and the primary outcome was a cognition composite score. The relationship between exposure and outcome was determined using Poisson regression with a robust error variance. RESULTS: We did not observe any association between maternal acetaminophen intake any time before or during pregnancy and low cognition composite score of offspring. The IRR of suboptimal overall cognition was 1.38 (0.78–2.45), 1.22 (0.67–2.22), 0.80 (0.44–1.47), and 1.56 (0.74–3.29) for maternal use of acetaminophen before, in early, late, or overall pregnancy, respectively. CONCLUSION: Current data do not provide evidence to support a relationship of maternal acetaminophen use during pregnancy with adverse cognitive effects at 4 years. IMPACT: Acetaminophen use during pregnancy may influence the risk of child neurocognitive disorders, but there is conflicting evidence of its relationship to sub-clinical measures of cognitive development such as executive function. The study design allowed us to examine the role of timing of acetaminophen use in its relationship with cognitive development, based on a validated and standardized tablet-administered instrument for children, instead of a teacher or parent report. We did not observe a clear relationship between maternal acetaminophen use at different timepoints during pregnancy and child cognitive development.
format Online
Article
Text
id pubmed-9261144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-92611442022-07-07 Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study Lye, Jennifer M. Knight, Julia A. Arneja, Jasleen Seeto, Ryan A. Wong, Jody Adel khani, Nadya Brooks, Jennifer D. Levitan, Robert D. Matthews, Stephen G. Lye, Stephen J. Hung, Rayjean J. Pediatr Res Clinical Research Article BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This study aimed to characterize the relationship between maternal acetaminophen use and cognitive development at 4 years. METHODS: This analysis included data collected throughout pregnancy and delivery from women in the Ontario Birth Study prospective cohort from 2013 to 2019 and from the NIH Toolbox Early Childhood Cognition battery administered to 4-year-old children between 2018 and 2021 (n = 436). The exposure was maternal acetaminophen use and the primary outcome was a cognition composite score. The relationship between exposure and outcome was determined using Poisson regression with a robust error variance. RESULTS: We did not observe any association between maternal acetaminophen intake any time before or during pregnancy and low cognition composite score of offspring. The IRR of suboptimal overall cognition was 1.38 (0.78–2.45), 1.22 (0.67–2.22), 0.80 (0.44–1.47), and 1.56 (0.74–3.29) for maternal use of acetaminophen before, in early, late, or overall pregnancy, respectively. CONCLUSION: Current data do not provide evidence to support a relationship of maternal acetaminophen use during pregnancy with adverse cognitive effects at 4 years. IMPACT: Acetaminophen use during pregnancy may influence the risk of child neurocognitive disorders, but there is conflicting evidence of its relationship to sub-clinical measures of cognitive development such as executive function. The study design allowed us to examine the role of timing of acetaminophen use in its relationship with cognitive development, based on a validated and standardized tablet-administered instrument for children, instead of a teacher or parent report. We did not observe a clear relationship between maternal acetaminophen use at different timepoints during pregnancy and child cognitive development. Nature Publishing Group US 2022-07-07 2023 /pmc/articles/PMC9261144/ /pubmed/35794252 http://dx.doi.org/10.1038/s41390-022-02182-w Text en © The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Research Article
Lye, Jennifer M.
Knight, Julia A.
Arneja, Jasleen
Seeto, Ryan A.
Wong, Jody
Adel khani, Nadya
Brooks, Jennifer D.
Levitan, Robert D.
Matthews, Stephen G.
Lye, Stephen J.
Hung, Rayjean J.
Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title_full Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title_fullStr Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title_full_unstemmed Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title_short Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
title_sort maternal acetaminophen use and cognitive development at 4 years: the ontario birth study
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261144/
https://www.ncbi.nlm.nih.gov/pubmed/35794252
http://dx.doi.org/10.1038/s41390-022-02182-w
work_keys_str_mv AT lyejenniferm maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT knightjuliaa maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT arnejajasleen maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT seetoryana maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT wongjody maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT adelkhaninadya maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT brooksjenniferd maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT levitanrobertd maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT matthewsstepheng maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT lyestephenj maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy
AT hungrayjeanj maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy